Literature DB >> 27067347

Drug-induced bullous pemphigoid.

Satoko M Kanahara1,2, Anoop Agrawal3.   

Abstract

Keywords:  ambulatory care; dermatology; diagnosis; disease management; drug reaction

Mesh:

Year:  2016        PMID: 27067347      PMCID: PMC5071269          DOI: 10.1007/s11606-016-3679-1

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  5 in total

Review 1.  Bullous pemphigoid: from bench to bedside.

Authors:  Scott R A Walsh; David Hogg; P Régine Mydlarski
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Drug-induced pemphigoid: a review of the literature.

Authors:  P G Stavropoulos; E Soura; C Antoniou
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-01-10       Impact factor: 6.166

3.  "Half-half" blisters in bullous pemphigoid successfully treated with adjuvant high-dose intravenous immunoglobulin.

Authors:  David Pacheco; Leonor Lopes; Luis Soares-Almeida; Manuel Sacramento Marques; Paulo Filipe
Journal:  Acta Dermatovenerol Alp Pannonica Adriat       Date:  2012-09

Review 4.  Severe drug-induced dermatoses.

Authors:  Iris Ahronowitz; Lindy Fox
Journal:  Semin Cutan Med Surg       Date:  2014-03

Review 5.  Furosemide-induced bullous pemphigoid: case report and review of literature.

Authors:  Jennifer J Lee; Thomas F Downham
Journal:  J Drugs Dermatol       Date:  2006-06       Impact factor: 2.114

  5 in total
  6 in total

Review 1.  Vegetating erosive cutaneous lesions and pyogenic granuloma in the course of mucous membrane pemphigoid: a case report and review of literature.

Authors:  Beata Jakubowska; Cezary Kowalewski; Norito Ishii; Takashi Hashimoto; Katarzyna Wozniak
Journal:  Int Wound J       Date:  2018-06-29       Impact factor: 3.315

2.  Cutaneous toxicities occurring during palbociclib (CDK4/6 inhibitor) and endocrine therapy in patients with advanced breast cancer: a single-centre experience.

Authors:  Sumir Chawla; Alison Hill; Louise Fearfield; Stephen Johnston; Marina Parton; Kara Heelan
Journal:  Breast Cancer Res Treat       Date:  2021-03-08       Impact factor: 4.872

3.  Association Between Medication Use and Bullous Pemphigoid: A Systematic Review and Meta-analysis.

Authors:  Sian-De Liu; Wei-Ti Chen; Ching-Chi Chi
Journal:  JAMA Dermatol       Date:  2020-08-01       Impact factor: 10.282

Review 4.  BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid.

Authors:  Yale Liu; Liang Li; Yumin Xia
Journal:  Front Immunol       Date:  2017-12-08       Impact factor: 7.561

Review 5.  Bullous pemphigoid in diabetic patients treated by gliptins: the other side of the coin.

Authors:  Karim Chouchane; Giovanni Di Zenzo; Dario Pitocco; Laura Calabrese; Clara De Simone
Journal:  J Transl Med       Date:  2021-12-20       Impact factor: 5.531

Review 6.  Bullous Pemphigoid: Trigger and Predisposing Factors.

Authors:  Francesco Moro; Luca Fania; Jo Linda Maria Sinagra; Adele Salemme; Giovanni Di Zenzo
Journal:  Biomolecules       Date:  2020-10-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.